What is the expected life expectancy after open‑heart surgery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Life Expectancy After Open Heart Surgery

Life expectancy after open heart surgery varies substantially by procedure type, age, and surgical risk, but for the most common procedure—coronary artery bypass grafting (CABG)—overall median survival is approximately 17-18 years, with younger, low-risk patients achieving significantly longer survival.

Survival by Procedure Type

Coronary Artery Bypass Grafting (CABG)

The most robust long-term data comes from CABG patients:

  • Overall median life expectancy: 17.6 years after first CABG surgery 1
  • 30-year survival data shows cumulative survival rates of 77% at 10 years, 40% at 20 years, and 15% at 30 years 1
  • 15-20 year outcomes demonstrate 5-year survival of 88%, 10-year survival of 73%, 15-year survival of 53%, and 20-year survival of 38% 2

Critical modifiers of CABG survival:

  • Extent of coronary disease: One-vessel disease yields 21.4 years median survival, two-vessel disease 18.8 years, and three-vessel disease 15.4 years (p<0.0001) 1
  • Left ventricular function: Normal LVEF provides 19.3 years median survival versus 13.9 years with impaired LVEF (p<0.0001) 1
  • Left main disease: Independently predicts mortality (HR 1.6) 1

Surgical Aortic Valve Replacement (SAVR)

For patients ≥60 years receiving bioprosthetic valves 3:

  • Low surgical risk (85% of patients): Median survival 10.9 years (95% CI: 10.6-11.2 years); 5-year mortality 16.5%
  • Intermediate surgical risk (11%): Median survival 7.3 years (7.0-7.9 years); 5-year mortality 30.7%
  • High surgical risk (3.5%): Median survival 5.8 years (5.4-6.5 years); 5-year mortality 43.0%

Age-specific survival in low-risk SAVR patients ranges from 16.2 years (ages 60-64) to 6.1 years (age ≥85) 3.

Thoracic Aortic Surgery

Expected survival is more limited 4:

  • 5-year survival: approximately 60% for degenerative and aortic dissection repairs in patients averaging lower 70s in age
  • Young patients with bicuspid valve/root-sparing procedures: 80-90% survival at 10 years
  • Acute aortic dissection patients: Dismal 50% 5-year survival even after surgery due to residual dissected aorta complications

Age-Specific Considerations

Elderly Patients (≥70 years)

Patients aged 70+ undergoing open heart surgery demonstrate excellent outcomes 5:

  • 5-year survival: 85%, comparable to age- and gender-matched general population
  • Quality of life scores similar to or better than US population norms for this age group
  • Survival declines with increasing comorbidities

For patients 70+ undergoing CABG 6:

  • Ages 50-79: 2.8% operative mortality
  • Ages 80-89: 7.1% operative mortality
  • Ages ≥90: 11.8% operative mortality
  • Nonagenarians without renal failure, IABP, emergency surgery, or vascular disease: only 7.2% operative mortality

Very Elderly (≥85 years)

Patients 85+ can achieve acceptable outcomes with careful selection 7:

  • Operative mortality: 12.3%; in-hospital death probability: 8.2%
  • 1-year survival: 75%
  • 3-year survival: 67%
  • 5-year survival: 40%
  • Key predictors of 30-day mortality: EF <30% (p=0.029) and postoperative renal failure (p=0.0039)

Critical Pitfalls and Caveats

Reoperative Surgery

Each subsequent reoperation significantly reduces survival 8:

  • Overall 30-day mortality: 13.6%
  • 1-year mortality: 21.2%
  • Multivariate predictors of lower survival: reoperative valve surgery, intraoperative ECMO use, and greater number of reoperations

Long-term Reintervention Rates

The majority of CABG patients require repeat intervention 1:

  • 36% of patients underwent coronary reintervention over 30 years
  • Cumulative freedom from death and reintervention: 60% at 10 years, 20% at 20 years, only 6% at 30 years
  • This confirms CABG as palliative treatment of progressive disease

Congenital Heart Disease

For tetralogy of Fallot repairs 9:

  • 35-year survival: approximately 85%
  • Reintervention need increases after second decade of life

Practical Clinical Algorithm

When counseling patients about life expectancy:

  1. Identify procedure type (CABG, valve, aortic, congenital)
  2. Assess surgical risk using validated scores (EuroSCORE II for valve procedures)
  3. Stratify by age (<65-79,80-89, ≥90 years)
  4. Evaluate key prognostic factors:
    • LV function (most critical for CABG)
    • Extent of coronary disease
    • Comorbidities (renal failure, diabetes, vascular disease)
    • Emergency vs. elective status
  5. Apply procedure-specific survival estimates from above data
  6. Adjust expectations for reoperations (substantially worse outcomes)

The evidence strongly supports that appropriately selected elderly patients, even octogenarians and nonagenarians, can achieve meaningful survival and quality of life after open heart surgery 6, 5, 7. However, honest discussions must include the palliative nature of many procedures, particularly CABG, where the majority will require reintervention during their remaining lifespan 1.

References

Research

Survival 15 to 20 years after coronary bypass surgery for angina.

Journal of the American College of Cardiology, 1993

Research

Life Expectancy After Surgical Aortic Valve Replacement.

Journal of the American College of Cardiology, 2021

Research

Open heart surgery in patients 85 years and older.

Journal of cardiac surgery, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.